Bipartisan bill aims to crack down on ‘tranq’

Bipartisan lawmakers in the House and Senate introduced legislation Tuesday to crack down on the illegal use of a veterinary tranquilizer that is increasingly being found in fentanyl and other drugs.

Xylazine, also known as “tranq,” is an easily accessible veterinary drug approved for use in animals as a sedative and pain reliever. But it is also being used by drug dealers as a low-cost cutting agent in illicit drugs.

The legislation would list xylazine as a Schedule III controlled substance on the five-tiered scale, meaning it has a “moderate to low potential for physical and psychological dependence.” Other Schedule III drugs include ketamine and anabolic steroids. Marijuana is a schedule I drug, defined as a drug “with no currently accepted medical use and a high potential for abuse.”

The bill would also enable theDrug Enforcement Administration (DEA) to track the manufacturing of xylazine to ensure it is not diverted to the illicit market.

Veterinarians legitimately use drug products containing xylazine to sedate large animals such as horses and deer, but it is not safe for use in people and may cause serious and life-threatening side effects.

Among the side effects of tranq are ulcers that crop up on various parts of the body, which sometimes lead to the loss of fingers or limbs. Xylazine is not an opioid, so the opioid overdose reversal drug naloxone does not work on it.

Last month, the Food and Drug Administration (FDA) said it would restrict imports of xylazine, meaning shipments of the animal tranquilizer face heightened FDA scrutiny.

The DEA issued a safety alert earlier this month and said its laboratory system found the tranquilizer in about 23 percent of seized fentanyl powder and 7 percent of fentanyl pills last year.

“Drug traffickers are going to great lengths to pad their profits with dangerous drugs like tranq, and we need to empower law enforcement to crack down on its spread in our communities,” said Senator Cortez Masto (D-Nev.), one of the lead Senate co-sponsors. “This bipartisan legislation will ensure the DEA and local law enforcement have the tools they need to get xylazine off our streets while protecting its important use as a veterinary tranquilizer.”

Other Senate sponsors include Sens. Chuck Grassley (R-Iowa) and Maggie Hassan (D-N.H.). The House bill is backed by lawmakers including Reps. Jimmy Panetta (D-Calif.), Chris Pappas (D-N.H.), Ken Buck (R- Colo.) and August Pfluger (R-Texas).

Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

You May Also Like

Moment CNN anchor refuses to comment on reporter’s coverage on thousands flocking to touch dead nun 

CNN anchor Jim Sciutto blatantly refused to comment on a story about…

Black actors on hit TV show Lost claim set was ‘poisonous’ and ‘toxic’

Black actors and screenwriters have accused the showrunners of hit TV show…

Chris Christie Prepares to Cement His Irrelevance With 2024 Disruption

The crowded 2024 field is about to see another entrant. After long-suggesting…

Chinese Defense Minister Rejects Meeting with U.S. Defense Secretary

China on Monday rejected a request from Defense Secretary Lloyd Austin to…

Reserve Bank Governor Philip Lowe says high population growth means higher rents, house prices

Australia’s most powerful banker has linked record population growth from immigration with…

Wife of man who saved two toddlers from a burning car says ‘divine intervention’ made him stop

The wife of a Arizona man who saved two toddlers from a…

The Guardian view on the pandemic: forgotten, but not gone | Editorial

Once we could talk of nothing else. Now we barely speak of…

Ant McPartlin slips live on stage in chaotic entrance on first Britain’s Got Talent semi-final

Britain’s Got Talent got off to a chaotic start on Monday night,…